The value of culture and serology for detection of Mycoplasma pneumoniae infections in the clinical laboratory in the age of molecular diagnostics

Clinical Microbiology Newsletter

Volumn 23, Issue 16, 2001, Pages 123-129

  Waites, Ken B ^a   Lanier Thacker, W ^b   Talkington, Deborah F ^b  

^a University of Alabama at Birmingham   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLD AGGLUTININ;

BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL EXAMINATION; COMPLEMENT FIXATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; LABORATORY DIAGNOSIS; MOLECULAR BIOLOGY; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; REVIEW; SEROLOGY;

EID: 0035882498     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(01)89042-5     Document Type: Review

References (23)

1. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients
2. The role of atypical pathogens in asthma
3. Mycoplasma and chlamydia are present in the airways of chronic, stable, asthmatics
4. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy and new implications from an old scenario
5. Epidemic Mycoplasma pneumoniae
6. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis
7. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio
8. Case records of the Massachusetts General Hospital, case 5-1992
9. Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly modified culture medium
10. Mycoplasma and ureaplasma
11. The limitation of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections
12. Evaluation of Meridian ImmunoCard mycoplasma test for the detection of Mycoplasma pneumoniae-specific IgM in pediatric patients
13. A micro-capture ELISA for detecting Mycoplasma pneumoniae IgM: Comparison with indirect immunofluorescence and indirect ELISAs
14. Analysis of complement fixation and commercial enzyme immunoassay for detection of antibodies to Mycoplasma pneumoniae in human serum
15. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and mu-capture IgM methods
16. Diagnosis of Mycoplasma pneumoniae infection by specific IgM antibodies using a new capture-enzyme immunoassay
17. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial
18. Evaluation of five commercial tests: Complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology
19. Evaluation of a rapid enzyme immunoassay system for serologic diagnosis of Mycoplasma pneumoniae infection
20. An assessment of a new diagnostic indirect enzyme immunoassay for the detection of anti-Mycoplasma pneumoniae IgM
21. Comparison of two rapid commercial tests with complement fixation for serologic diagnosis of Mycoplasma pneumoniae infections
22. Diagnosis of Mycoplasma pneumoniae infection in autopsy and open-lung biopsy tissues by nested PCR
23. Development of a TaqMan probe-based PCR with customized internal controls for detecting Mycoplasma pneumoniae and Mycoplasma fermentans, G-I8